Clinicians can evaluate the reliability of results by checking the heart rhythm graph generated during the exam. Credit: ec-jpr.

Telehealth company Tyto Care has launched its US Food and Drug Administration (FDA)-cleared fingertip Pulse Oximeter (SpO2) medical device for checking blood oxygen saturation levels and heart rate remotely.

The virtual examination solution used in the home setting can support clinicians in monitoring patients with Covid-19 and chronic lung or heart conditions, helping them avoid hospital and clinic visits.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Pulse Oximeter connects to TytoCare device by a cable. Users can carry out blood oxygen exam by placing their finger in the SpO2 device for 15 seconds.

The blood oxygen and heart rate results will soon appear on the handheld device and the Pulse Oximeter adaptor. The results are logged in the TytoCare platform for clinician’s review and are sent to patients’ Electronic Health Record (EHR).

Furthermore, if the exam is conducted in real time during a live telehealth visit, the clinician can see the results in the TytoCare Clinician Dashboard.

The reliability of results can be evaluated by checking the heart rhythm graph generated during the exam.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Tyto Care CEO and co-founder Dedi Gilad said: “We’re excited to announce the release of our Pulse Oximeter, providing patients with more tests that bring the clinic directly to them.

“The Covid-19 pandemic thrust telehealth into the spotlight, and we are constantly enhancing the TytoCare platform to ensure users have access to the most comprehensive telehealth solution available.

“The pandemic will eventually be behind us, yet telehealth will remain a key component in the future of healthcare, providing patients with the best possible remote care and clinicians with actionable insights into their patients’ health.”

Through partnering health systems, Tyto Care’s Pulse Oximeter is available in the US and Israel.

The company plans to make the device available in Europe, South Africa, and Asia in the future.